Pomyśl o wsparciu dla jelit! Kompleks probiotyków, które dbają o dobrostan flory jelitowej.
Bifidobacterium infantis
* Scully, P., Macsharry, J., O’Mahony, D., Lyons, A., O’Brien, F., Murphy, S., … & O’Mahony, L. (2013). Bifidobacterium infantis suppression of Peyer’s patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+ CD25+ T cell numbers. Cellular immunology, 281(2), 134-140.
** O’Hara, A. M., O’Regan, P., Fanning, Á., O’Mahony, C., MacSharry, J., Lyons, A., … & Shanahan, F. (2006). Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology, 118(2), 202-215.
*** Lyseng-Williamson, K. A. (2017). Bifidobacterium infantis 35624 as a probiotic dietary supplement: a profile of its use. Drugs & Therapy Perspectives, 33(8), 368-374.
**** Ewaschuk, J. B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., … & Madsen, K. L. (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. American journal of physiology-gastrointestinal and liver physiology, 295(5), G1025-G1034.
***** Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O’mahony, L., … & Quigley, E. M. (2006). Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Official journal of the American College of Gastroenterology| ACG, 101(7), 1581-1590.
Lactobacillus plantarum
* Ducrotté, P., Sawant, P., & Jayanthi, V. (2012). Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World journal of gastroenterology: WJG, 18(30), 4012.
de Vos, P., Mujagic, Z., de Haan, B. J., Siezen, R. J., Bron, P. A.,
** Meijerink, M., … & Troost, F. J. (2017). Lactobacillus plantarum strains can enhance human mucosal and systemic immunity and prevent non-steroidal anti-inflammatory drug induced reduction in T regulatory cells. Frontiers in immunology, 8, 1000.
Lactobacillus rhamnosus
* Segers, M. E., & Lebeer, S. (2014). Towards a better understanding of Lactobacillus rhamnosus GG-host interactions. Microbial cell factories, 13(1), 1-16.
** ong, F. L. Y., Kirjavainen, P. V., & El-Nezami, H. (2016). Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived soluble factors on antigen-presenting cells of healthy blood donors. Scientific reports, 6(1), 1-8.
*** Yan, F., & Polk, D. B. (2012). Lactobacillus rhamnosus GG: an updated strategy to use microbial products to promote health. Functional food reviews (Print), 4(2), 77.
**** Pedersen, N., Andersen, N. N., Végh, Z., Jensen, L., Ankersen, D. V., Felding, M., … & Munkholm, P. (2014). Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World Journal of Gastroenterology: WJG, 20(43), 16215.
Dozowanie
Przechowywanie
Środki ostrożności
Bez konserwantów
Bez sztucznych barwników
Bez GMO
Bez herbicydów i innych pestycydów
Bez laktozy
Bez glutenu
15.1 Ducrotté, P., Sawant, P., & Jayanthi, V. (2012). Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World journal of gastroenterology: WJG, 18(30), 4012.
de Vos, P., Mujagic, Z., de Haan, B. J., Siezen, R. J., Bron, P. A., Meijerink, M., … & Troost, F. J. (2017). Lactobacillus plantarum strains can enhance human mucosal and systemic immunity and prevent non-steroidal anti-inflammatory drug induced reduction in T regulatory cells. Frontiers in immunology, 8, 1000.
15.2 Scully, P., Macsharry, J., O’Mahony, D., Lyons, A., O’Brien, F., Murphy, S., … & O’Mahony, L. (2013). Bifidobacterium infantis suppression of Peyer’s patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+ CD25+ T cell numbers. Cellular immunology, 281(2), 134-140.
O’Hara, A. M., O’Regan, P., Fanning, Á., O’Mahony, C., MacSharry, J., Lyons, A., … & Shanahan, F. (2006). Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology, 118(2), 202-215.
Lyseng-Williamson, K. A. (2017). Bifidobacterium infantis 35624 as a probiotic dietary supplement: a profile of its use. Drugs & Therapy Perspectives, 33(8), 368-374.
Ewaschuk, J. B., Diaz, H., Meddings, L., Diederichs, B., Dmytrash, A., Backer, J., … & Madsen, K. L. (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. American journal of physiology-gastrointestinal and liver physiology, 295(5), G1025-G1034.
Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O’mahony, L., … & Quigley, E. M. (2006). Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Official journal of the American College of Gastroenterology| ACG, 101(7), 1581-1590.
15.3 Segers, M. E., & Lebeer, S. (2014). Towards a better understanding of Lactobacillus rhamnosus GG-host interactions. Microbial cell factories, 13(1), 1-16.
Fong, F. L. Y., Kirjavainen, P. V., & El-Nezami, H. (2016). Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived soluble factors on antigen-presenting cells of healthy blood donors. Scientific reports, 6(1), 1-8.
Yan, F., & Polk, D. B. (2012). Lactobacillus rhamnosus GG: an updated strategy to use microbial products to promote health. Functional food reviews (Print), 4(2), 77.
Pedersen, N., Andersen, N. N., Végh, Z., Jensen, L., Ankersen, D. V., Felding, M., … & Munkholm, P. (2014). Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World Journal of Gastroenterology: WJG, 20(43), 16215.
Zuzanna –
Probiotyki są po prostu potrzebne z racji tego co jemy często niezdrowego czy przetworzonego 🙂
Gosia –
Polecam, ustąpiły uciążliwe wzdęcia i uczucie pełności w brzuchu 🙂